We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.
In cooperation with Association of Corporate Counsel
  Request new password

Search results

Order by most recent / most popular / relevance

Results: 11-20 of 1,486

Conditional pricing practices in the U.S. spotlight

  • Jones Day
  • -
  • USA
  • -
  • July 2 2014

On June 23, 2014, the Federal Trade Commission ("FTC") and the Antitrust Division of the U.S. Department of Justice ("DOJ") hosted a one day workshop

Pharmaceutical & medical device regulatory update, issue 9

  • Jones Day
  • -
  • USA
  • -
  • July 1 2014

In a draft guidance issued on June 20, FDA announced it does not intend to enforce compliance with regulations governing medical device data systems

Fifth Circuit clarifies meaning of "false" claim under False Claims Act

  • Jones Day
  • -
  • USA
  • -
  • June 30 2014

The recent explosion of cases arising under the False Claims Act ("FCA") certainly has caught the attention of those who do business with the

Fifth Third Bancorp v. Dudenhoeffer: Supreme Court rejects "presumption of prudence" for stock drop cases

  • Jones Day
  • -
  • USA
  • -
  • June 30 2014

On June 25, the United States Supreme Court issued its decision in Fifth Third Bancorp v. Dudenhoeffer, a decision that had been highly anticipated

Euroresourcedeals and debt - June 2014

  • Jones Day
  • -
  • European Union, USA
  • -
  • June 30 2014

On 16 June 2014, despite the Republic of Argentina's warning that it may once again be forced to default on its sovereign debt, the US Supreme Court

FERC acts to ensure that utility cost-based rates include an adequate return on equity

  • Jones Day
  • -
  • USA
  • -
  • June 30 2014

In June, the Federal Energy Regulatory Commission ("FERC" or "Commission") issued Opinion No. 531, which details three significant changes to the way

FDA finalizes guidance document on Expedited Programs for Serious Conditions

  • Jones Day
  • -
  • USA
  • -
  • June 27 2014

On May 30, 2014, FDA finalized its Guidance for Industry: Expedited Programs for Serious Conditions - Drugs and Biologics. The draft guidance

Time running out to file comments on OIG proposed rulemaking that gives OIG limitless time to exclude providers

  • Jones Day
  • -
  • USA
  • -
  • June 26 2014

Statutes of limitation serve an essential purpose in ensuring that claims are timely pursued before evidence becomes stale, and that parties can

Supreme Court invalidates NLRB recess appointments

  • Jones Day
  • -
  • USA
  • -
  • June 26 2014

In a decisive victory for Jones Day client Noel Canning, today the United States Supreme Court ruled unanimously that President Obama's three January

Food, dietary supplement & cosmetics regulatory update, issue 8

  • Jones Day
  • -
  • USA
  • -
  • June 25 2014

On June 24, FDA issued three final guidance documents on the use of nanotechnology in FDA-regulated products. The guidance documents address whether